These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 17134848

  • 21. Chromium in metabolic and cardiovascular disease.
    Hummel M, Standl E, Schnell O.
    Horm Metab Res; 2007 Oct; 39(10):743-51. PubMed ID: 17952838
    [Abstract] [Full Text] [Related]

  • 22. Role of aldosterone and angiotensin II in insulin resistance: an update.
    Lastra-Lastra G, Sowers JR, Restrepo-Erazo K, Manrique-Acevedo C, Lastra-González G.
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
    [Abstract] [Full Text] [Related]

  • 23. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C, Fu Y, Chung BH, Garvey WT.
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [Abstract] [Full Text] [Related]

  • 24. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M, Olofsson SO, Taskinen MR, Borén J.
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
    [Abstract] [Full Text] [Related]

  • 25. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M, Abate N.
    J Diabetes Complications; 2007 Jul; 21(2):128-36. PubMed ID: 17331862
    [Abstract] [Full Text] [Related]

  • 26. Adipose tissue macrophages.
    Zeyda M, Stulnig TM.
    Immunol Lett; 2007 Oct 15; 112(2):61-7. PubMed ID: 17719095
    [Abstract] [Full Text] [Related]

  • 27. Renin-angiotensin-system blockade in the prevention of diabetes.
    Ostergren J.
    Diabetes Res Clin Pract; 2007 May 15; 76 Suppl 1():S13-21. PubMed ID: 17320999
    [Abstract] [Full Text] [Related]

  • 28. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB, Wilson PW.
    Diabetes Care; 2007 May 15; 30(5):1219-25. PubMed ID: 17259468
    [Abstract] [Full Text] [Related]

  • 29. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 15; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 30. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
    Pedersen-Bjergaard U, Dhamrait SS, Sethi AA, Frandsen E, Nordestgaard BG, Montgomery HE, Pramming S, Hougaard P, Thorsteinsson B.
    Am J Med; 2008 Mar 15; 121(3):246.e1-8. PubMed ID: 18328310
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ghrelin in Type 2 diabetes mellitus and metabolic syndrome.
    Ukkola O.
    Mol Cell Endocrinol; 2011 Jun 20; 340(1):26-8. PubMed ID: 21419192
    [Abstract] [Full Text] [Related]

  • 33. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR.
    Expert Rev Cardiovasc Ther; 2008 Mar 20; 6(3):343-68. PubMed ID: 18327995
    [Abstract] [Full Text] [Related]

  • 34. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould A.
    Diabetes Metab Res Rev; 2008 Oct 20; 24(7):520-32. PubMed ID: 18615851
    [Abstract] [Full Text] [Related]

  • 35. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.
    Roberge C, Carpentier AC, Langlois MF, Baillargeon JP, Ardilouze JL, Maheux P, Gallo-Payet N.
    Am J Physiol Endocrinol Metab; 2007 Dec 20; 293(6):E1465-78. PubMed ID: 17911338
    [Abstract] [Full Text] [Related]

  • 36. Neuroendocrine mechanisms in insulin resistance.
    Sjöstrand M, Eriksson JW.
    Mol Cell Endocrinol; 2009 Jan 15; 297(1-2):104-11. PubMed ID: 18599191
    [Abstract] [Full Text] [Related]

  • 37. [Physiological role of angiotensin II and IV as active components of the renin-angiotensin system].
    Prozherina IuA.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2008 Jan 15; 58(6):649-62. PubMed ID: 19178068
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Acid-base balance may influence risk for insulin resistance syndrome by modulating cortisol output.
    McCarty MF.
    Med Hypotheses; 2005 Jan 15; 64(2):380-4. PubMed ID: 15607573
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.